Form 8-K - Current report:
SEC Accession No. 0001104659-25-069029
Filing Date
2025-07-18
Accepted
2025-07-18 16:11:36
Documents
14
Period of Report
2025-07-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2521167d1_8k.htm   iXBRL 8-K 29607
2 EXHIBIT 99.1 tm2521167d1_ex99-1.htm EX-99.1 14364
6 GRAPHIC tm2521167d1_ex99-1img001.jpg GRAPHIC 4127
  Complete submission text file 0001104659-25-069029.txt   221359

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hook-20250718.xsd EX-101.SCH 3029
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20250718_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20250718_pre.xml EX-101.PRE 22368
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2521167d1_8k_htm.xml XML 3830
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 251134629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)